Amyloid-peptide β 42 Enhances the Oligomerization and Neurotoxicity of apoE4: The C-terminal Residues Leu279, Lys282 and Gln284 Modulate the Structural and Functional Properties of apoE4
Authors:
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 394, 144-155
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Topology of human apolipoprotein E3 uniquely regulates its diverse biological functionsProceedings of the National Academy of Sciences, 2011
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDSJournal of Lipid Research, 2009
- Biophysical Analysis of Progressive C-Terminal Truncations of Human Apolipoprotein E4: Insights into Secondary Structure and Unfolding PropertiesBiochemistry, 2008
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene‐related dementias: a morphological studyNeuropathology and Applied Neurobiology, 2006
- Amino-terminal Domain Stability Mediates Apolipoprotein E Aggregation into Neurotoxic FibrilsJournal of Molecular Biology, 2006
- Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.Journal of Clinical Investigation, 1994
- Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholineBiochemistry, 1973